Diana V Do, Charles C Wykoff, Sobha Sivaprasad, David M Brown, David S Boyer, Taiji Sakamoto, Peter Win, Sunir Joshi, Hani Salehi-Had, András Seres, Alyson J Berliner, Sergio Leal, Robert Vitti, Karen W Chu, Kimberly Reed, Yenchieh Cheng, Rafia Bhore, Zhanying Bai, Ursula Schmidt-Ott, Thomas Schmelter, Andrea Schulze, Zoran Hasanbasic, Peter J Morgan-Warren, Xin Zhang, Boaz Hirshberg, George D Yancopoulos, PHOTON Investigators
چکیده
To follow up the previously published comparison of aflibercept 8 mg at extended dosing intervals versus aflibercept 2 mg every 8 weeks (2q8) in patients with diabetic macular edema (DME) through 48 weeks, we now report efficacy, durability, and safety analyses through 96 weeks. PHOTON…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1016/j.ophtha.2025.10.028